Monitoring and maintaining health — OCR GCSE Biology
Monitoring and maintaining health explained
Monitoring and maintaining health covers 29 specification points, including Translate information between graphical and… and Construct and interpret frequency tables and….
Read the full explanation
Open a point below for its explanation and revision guidance.
translate information between graphical and numerical forms
Medical and public health data requires translating complex information between graphical plots and numerical values. Students must extract mortality or infection statistics from epidemiological graphs, convert disease prevalence figures into percentages or rates per 100,000 population, and calculate relative risk ratios. In cardiovascular health, learners translate blood pressure measurements and body mass index charts into quantitative risk categorisations, evaluating physiological status and identifying underlying non-communicable disease risk factors.
construct and interpret frequency tables and diagrams, bar charts and histograms
Epidemiological and physiological data must be displayed using correct graphical formats. Frequency tables organize clinical observations into discrete or continuous categories. Bar charts display categorical, discontinuous health data (such as rates of bacterial versus viral infections or blood groups), with distinct gaps between bars. In contrast, histograms represent continuous variables (such as patient age distributions, resting heart rates, or blood cholesterol levels), where bars touch and the area under the bar reflects frequency density across class intervals.
understand the principles of sampling as applied to scientific data
Sampling principles in clinical trials and epidemiological research ensure that findings are statistically valid, unbiased, and generalisable to human populations. Large, randomized sample cohorts eliminate selection bias. In pharmaceutical drug trials, representative patient cohorts matched for age, biological sex, and baseline health conditions are recruited. Sample sizes must be sufficiently large to detect small therapeutic effects, calculate statistical significance, and identify rare adverse side effects that would remain undetected in small test groups.
use a scatter diagram to identify a correlation between two variables
Scatter graphs plot paired health variables to evaluate relationships between lifestyle risk factors and disease incidence. A positive correlation indicates that as one variable rises, the other increases, such as daily cigarette consumption and lung cancer incidence. A negative correlation shows one variable decreasing as the other rises, such as weekly aerobic exercise and resting heart rate. Crucially, students must distinguish correlation from causation; correlation establishes an association, but proving causation requires demonstrating an underlying biological mechanism.
calculate cross-sectional areas of bacterial cultures and clear agar jelly using πr²
In microbiological assays testing antiseptic or antibiotic efficacy, filter paper discs soaked in antimicrobial agents are placed on inoculated agar lawns. Clear circular zones of inhibition form where bacterial growth is prevented. To quantify antimicrobial potency, candidates measure the diameter across two perpendicular axes, divide by two to calculate the radius r, and apply the formula A = πr² to determine the cross-sectional area in mm². Larger clear zones indicate greater antimicrobial effectiveness against the cultured bacterial strain.
describe the relationship between health and disease
Health is defined by the World Health Organization as a state of complete physical, mental, and social well-being, rather than merely the absence of disease or infirmity. A disease is a physiological or psychological condition that impairs normal bodily or cellular functioning, producing characteristic clinical symptoms and signs. Health and disease exist along a dynamic continuum: diseases degrade overall health directly through organ dysfunction, while poor physical or social environments increase vulnerability to developing communicable and non-communicable illnesses.
describe different types of diseases (to include: communicable and non-communicable diseases)
Diseases are classified into two fundamental biological categories: communicable and non-communicable. Communicable diseases are infectious illnesses caused by biological pathogens (including viruses, bacteria, fungi, and protists) that can be transmitted between host individuals via air, direct contact, water, or vectors. Examples include influenza, measles, and malaria. Non-communicable diseases cannot be transmitted from person to person; they develop over time due to genetic predispositions, lifestyle habits (such as smoking, poor diet, and alcohol), or environmental factors, including cardiovascular diseases, cancers, and type 2 diabetes.
describe the interactions between different types of disease (to include: HIV and tuberculosis; HPV and cervical cancer)
Diseases frequently interact, where infection with one condition increases vulnerability to another. A major clinical interaction occurs between Human Immunodeficiency Virus (HIV) and tuberculosis (TB). HIV infects and destroys helper T lymphocytes, severely suppressing adaptive immune responses; this immunodeficiency allows opportunistic bacteria like Mycobacterium tuberculosis to cause severe, active lung disease. Another interaction involves Human Papillomavirus (HPV) and cervical cancer: high-risk strains of sexually transmitted HPV integrate viral DNA into cervical epithelial cells, disrupting normal cell cycle controls and triggering malignant cervical cancer tumours.
explain how communicable diseases (caused by viruses, bacteria, protists and fungi) are spread in animals and plants (to include: scientific quantities, number of pathogens, number of infected cases, estimating number of cases)
Pathogens spread through distinct transmission routes in animal and plant hosts. Transmission vectors include airborne water droplets from coughing or sneezing (influenza, measles), direct skin or sexual contact (HIV, chlamydia), contaminated water or food (cholera, Salmonella), biological vectors like mosquitoes (malaria protist), and wind, rain splash, or contaminated tools in plants (tobacco mosaic virus, powdery mildew). The probability of establishing an infection depends on pathogen load and host immune competence. Epidemiologists track transmission dynamics by quantifying confirmed cases and estimating true prevalence across populations using representative sampling.
explain how the spread of communicable diseases may be reduced or prevented in animals and plants (to include: detection of the antigen, DNA testing, visual identification of the disease)
Controlling communicable disease transmission requires rapid detection and preventative barriers. Diagnostic methods include visual identification of symptoms (e.g. leaf spots, mosaic patterns, or skin rashes), detection of pathogen-specific antigens using monoclonal antibody test kits (e.g. rapid flow tests), and polymerase chain reaction (PCR) DNA testing to amplify and identify pathogen genomes with high precision. Preventative measures in animals include handwashing, quarantine of infected cases, vector eradication, and mass vaccination to achieve herd immunity. In agriculture, transmission is curbed by destroying infected crops, crop rotation, and sterilising machinery.
describe a minimum of one common human infection, one plant disease and sexually transmitted infections in humans including HIV/AIDS (to include: human infections: one example of each viral, fungal, bacterial plant diseases: viral tobacco mosaic virus TMV, fungal Erysiphe graminis barley powdery mildew, bacterial Agrobacterium tumefaciens crown gall disease)
Pathogens cause characteristic diseases in humans and plants. Human examples: measles is viral, spread by airborne droplets, causing fever and red rash; Salmonella is bacterial, from contaminated food, causing vomiting and diarrhoea; athlete's foot is fungal, causing itchy peeling skin. HIV is a sexually transmitted retrovirus that destroys helper T cells; AIDS is the late stage of immune deficiency, not the same as HIV. Plant examples: tobacco mosaic virus (TMV) gives mottled leaf discolouration, reducing chlorophyll so less light is absorbed, less photosynthesis occurs and growth is stunted; the fungus Erysiphe graminis causes barley powdery mildew, coating leaves with white hyphae; the bacterium Agrobacterium tumefaciens transfers plasmid DNA into plant cells, inducing crown gall tumours.
describe physical plant defence responses to disease (to include: leaf cuticle, cell wall) (content found only in the biology separate science qualification)
Plants possess passive physical barriers that prevent pathogens from entering plant tissues. The waxy leaf cuticle forms an impermeable, hydrophobic lipid layer covering the upper and lower epidermal surfaces, preventing water accumulation where fungal spores could germinate and blocking microbial entry. Beneath the cuticle, tough cell walls composed of cellulose microfibrils provide a rigid mechanical barrier around individual plant cells, stopping bacterial and fungal hyphae from invading the cytoplasm. Additional physical defences include layers of dead bark cells on tree trunks that shed regularly, carrying pathogens away.
describe chemical plant defence responses (to include: antimicrobial substances) (content found only in the biology separate science qualification)
When physical barriers are breached, plants deploy chemical defence responses to inhibit or kill pathogens. Many plants synthesize antimicrobial compounds that disrupt bacterial cell membranes or inhibit microbial enzyme systems. For example, garlic produces allicin, which possesses potent antibacterial properties; witch hazel produces astringent tannins that deter herbivores and inhibit pathogen growth. Humans have harnessed these plant defence chemicals for medicinal pharmaceuticals, including the extraction of aspirin (an analgesic derived from salicin in willow bark) and digitalis for cardiac arrhythmias from foxgloves.
describe different ways plant diseases can be detected and identified, in the lab and in the field (to include: the laboratory detection of the DNA or antigen from the disease causing organism. The field diagnosis by observation and microscopy) (content found only in the biology separate science qualification) (Higher tier only)
Diagnosing plant diseases involves field observation and laboratory analysis. In the field, agronomists inspect crops for macroscopic symptoms such as leaf spots, mosaic discolouration, wilting, galls, or stunting, consulting horticultural reference guides or dichotomous keys; portable light microscopes examine tissue smears for fungal spores or bacterial exudates. In diagnostic laboratories, advanced molecular techniques ensure definitive identification: monoclonal antibody test kits bind pathogen-specific antigens via ELISA assays, and PCR DNA testing amplifies unique pathogen DNA sequences, allowing precise pathogen identification before widespread crop damage occurs.
explain how white blood cells and platelets are adapted to their defence functions in the blood
Blood contains specialized components adapted for internal host defence. White blood cells are divided into phagocytes and lymphocytes. Phagocytes (such as neutrophils and macrophages) have flexible cell membranes and lobed nuclei, enabling them to squeeze between capillary endothelial cells into infected tissues; they engulf pathogens by phagocytosis and fuse with lysosomes containing digestive enzymes to destroy them. Lymphocytes produce specific Y-shaped antibodies that bind to pathogen antigens and release antitoxins to neutralise bacterial toxins. Platelets are small, non-nucleated cell fragments; upon blood vessel damage, they initiate the clotting cascade, producing insoluble fibrin protein meshes that trap red blood cells to form scabs, preventing blood loss and pathogen entry.
describe the non-specific defence systems of the human body against pathogens
The human body possesses non-specific primary defence systems that block pathogen entry regardless of pathogen species. The skin forms an unbroken, tough physical barrier, covered in sebum with antimicrobial properties and shedding dead surface cells. In the respiratory system, nasal hairs trap inhaled particles, goblet cells secrete sticky mucus to entrap pathogens, and ciliated epithelial cells rhythmically beat to sweep mucus upward to the pharynx to be swallowed. In the digestive tract, stomach hydrochloric acid (pH 1 to 2) provides a chemical barrier, denaturing pathogen enzymes and killing ingested microorganisms. In addition, tears produce the antimicrobial enzyme lysozyme to wash and protect eye surfaces.
explain the role of the immune system of the human body in defence against disease
The specific immune system mounts targeted cellular and chemical defences against foreign pathogens that bypass non-specific primary barriers. Pathogens display unique molecular markers called antigens on their surface. Specific B lymphocytes recognise complementary antigens, stimulating these cells to divide by mitosis into clones of plasma cells that secrete large quantities of targeted antibodies. These antibodies bind to antigens, neutralizing pathogens, causing agglutination, or tagging them for destruction by phagocytic cells. Crucially, a subset of lymphocytes develops into long-lived memory cells that persist in lymphatic tissue, enabling a much faster, higher-titre secondary immune response upon reinfection, conferring lasting immunity.
describe how monoclonal antibodies are produced (content found only in the biology separate science qualification) (Higher tier only)
Monoclonal antibodies are identical antibodies specific to a single binding site on a target antigen, produced using hybridoma technology. A mouse is injected with a specific antigen, stimulating spleen B lymphocytes to make complementary antibodies. These antibody-producing lymphocytes are extracted from the mouse spleen and fused with tumour cells (myeloma cells), which possess the capacity to divide indefinitely in laboratory cell culture. The resulting hybrid cell is termed a hybridoma. Individual hybridoma cells are separated and cloned to produce large populations of identical cells that secrete identical monoclonal antibodies, which are collected and purified for clinical applications.
describe some of the ways in which monoclonal antibodies can be used (to include: their role in detecting antigens in pregnancy testing, detection of diseases (prostate cancer) and potentially treating disease (targeting cancer cells)) (content found only in the biology separate science qualification) (Higher tier only)
Monoclonal antibodies have revolutionized diagnostics and targeted therapies due to their singular antigen specificity. In home pregnancy test kits, mobile monoclonal antibodies linked to coloured dye particles bind human chorionic gonadotropin (hCG) hormone present in pregnant urine; the hCG-antibody complexes travel along the test strip and bind immobilized antibodies, concentrating the dye into a visible coloured line. In clinical diagnostics, fluorescently tagged monoclonal antibodies detect disease biomarkers such as prostate-specific antigen (PSA) in blood tests to diagnose prostate cancer. In therapeutics, monoclonal antibodies carry radioactive isotopes or cytotoxic drugs directly to tumour surface antigens, destroying malignant cancer cells without harming healthy somatic tissue.
explain the use of vaccines and medicines in the prevention and treatment of disease (to include: antibiotics, antivirals and antiseptics)
Vaccines and medicines prevent and treat disease through distinct biological mechanisms. Vaccines introduce dead, attenuated, or fragment pathogens containing specific antigens into the body. This stimulates lymphocytes to produce complementary antibodies and long-lived memory cells without causing illness, establishing active immunity; widespread uptake achieves herd immunity. Medicines treat active infections: antibiotics (like penicillin) specifically kill bacteria or inhibit their growth (e.g. disrupting peptidoglycan cell walls) without harming human cells, but are completely ineffective against viruses. Antivirals treat viral infections by inhibiting specific viral enzymes and replication stages inside host cells. Antiseptics are non-specific chemical antimicrobials applied externally to living skin to destroy pathogens and prevent wound infection.
explain the aseptic techniques used in culturing organisms (to include: use of alcohol, flaming, autoclaving of glassware and growth media, and measures used to stop contaminants falling onto/into the growth media (e.g. working around a Bunsen burner)) (content found only in the biology separate science qualification)
Aseptic techniques prevent contamination of pure microbial cultures and protect the investigator. Nutrient agar and glassware are sterilised in an autoclave using steam under pressure at 121 °C. Work surfaces are disinfected with alcohol. Metal inoculating loops are flamed in a roaring blue Bunsen burner until red hot to incinerate microbes, then cooled before transferring bacteria. Working close to a Bunsen flame creates an upward convection current carrying airborne microbes away from open plates. Petri dish lids are opened minimally at an angle, taped without airtight sealing to maintain aerobic conditions, and incubated inverted at a maximum of 25 °C in schools to prevent cultivating human pathogens.
describe the processes of discovery and development of potential new medicines (to include: preclinical and clinical testing)
Drug development proceeds through structured preclinical and clinical phases to establish safety, efficacy, and dosage. Preclinical testing takes place in laboratory settings, assessing the chemical on isolated human cells, cultured tissues, and live animals to determine basic efficacy, toxicity, and safe dosage ranges. If cleared, clinical trials commence on humans: Phase 1 administers very low doses to healthy volunteers to check safety and side effects; Phase 2 tests the drug on volunteer patients to evaluate clinical efficacy and refine dosage; Phase 3 conducts large-scale, double-blind trials comparing the drug against a placebo, where neither patients nor doctors know who receives the active drug, eliminating psychological and observer bias.
recall that many non-communicable human diseases are caused by the interaction of a number of factors (to include: cardiovascular diseases, many forms of cancer, some lung (bronchitis) and liver (cirrhosis) diseases and diseases influenced by nutrition, including type 2 diabetes)
Many non-communicable diseases develop through interacting genetic, environmental and lifestyle factors. Cardiovascular disease risk is linked to smoking, high blood pressure, inactivity and family history. Cancers can involve inherited susceptibility and DNA damage from carcinogens such as tobacco smoke. Smoke and air pollution also increase chronic bronchitis risk. Excessive alcohol intake or chronic hepatitis can lead to liver scarring called cirrhosis; the resulting disease is not transmitted, although a contributing infection can be. Obesity, diet, activity and inherited factors influence type 2 diabetes risk, in which cells respond less effectively to insulin. Risk factors change probability; they do not guarantee disease.
evaluate some different treatments for cardiovascular disease (to include: lifestyle, medical and surgical)
Cardiovascular disease (CVD) treatments include lifestyle changes, medicines and surgery. Lifestyle changes such as a diet low in saturated fat, stopping smoking and regular exercise are non-invasive and lower blood pressure, but depend on long-term patient adherence and cannot reverse established atheromas; exercise also carries some injury risk. Medical treatments include statins, which reduce liver cholesterol synthesis to slow plaque build-up, and antihypertensives; they require daily use and may cause side effects such as muscle aches or liver dysfunction. Surgical options include stents to widen narrowed coronary arteries, bypass grafts and heart transplants; surgery can restore blood flow quickly, but carries risks of infection and thrombosis, and transplants risk donor organ rejection, requiring lifelong immunosuppressants.
analyse the effect of lifestyle factors on the incidence of non-communicable diseases at local, national and global levels (to include: lifestyle factors to include exercise, diet, alcohol and smoking)
Epidemiological analysis links lifestyle factors to non-communicable disease incidence across geographic tiers. Locally, deprived urban areas exhibit higher smoking rates and lower access to affordable fresh food, correlating with elevated cardiovascular disease, obesity, and lower life expectancies. Nationally, developed countries like the UK face high rates of type 2 diabetes, hypertension, and colon cancer driven by sedentary lifestyles and energy-dense diets high in saturated fats and refined sugars, placing heavy financial burdens on healthcare systems. Globally, as developing countries industrialise and adopt Western diets alongside rising tobacco and alcohol consumption, non-communicable disease incidence now overtakes infectious diseases, straining public health budgets worldwide.
describe cancer as the result of changes in cells that lead to uncontrolled growth and division
Cancer arises from genetic mutations in cells that disrupt normal cell cycle regulation, causing cells to undergo uncontrolled growth and mitotic division, forming an abnormal tissue mass called a tumour. Tumours are classified as benign or malignant. Benign tumours remain contained within a fibrous capsule at the original site, do not invade neighbouring tissues, and do not spread around the body. Malignant tumours are cancerous: their cells invade neighbouring healthy tissues and can detach, travelling through the bloodstream or lymphatic system to establish secondary tumours (metastases) in distant organs. Carcinogens such as tobacco tar, ultraviolet radiation, and ionising radiation increase mutation rates.
discuss potential benefits and risks associated with the use of stem cells in medicine (to include: tissue transplantation and rejection)
Stem cells are undifferentiated biological cells capable of self-renewal and differentiating into specialized cell types. Embryonic stem cells are pluripotent, capable of differentiating into any cell type, offering potential to treat paralysis, macular degeneration, and type 1 diabetes by replacing destroyed cells. Adult stem cells (e.g. from bone marrow) are multipotent, forming limited tissues such as blood cells. Clinical risks include immune rejection: donor cells display foreign antigens, provoking immune attack unless suppressed by lifelong immunosuppressive drugs. Furthermore, rapidly dividing stem cells carry risks of tumour formation, and using human embryos raises serious ethical controversies regarding the destruction of potential human life. Therapeutic cloning can overcome rejection by using patient nuclei.
explain some of the possible benefits and risks of using gene technology in medicine (to include: practical and ethical considerations)
Gene technology in clinical medicine encompasses recombinant DNA technology and gene therapy. Recombinant bacteria engineered with human genes produce abundant, pure therapeutic proteins, such as human insulin for diabetes and factor VIII for haemophilia, eliminating risks of animal pathogen transmission. Gene therapy aims to correct genetic disorders (such as cystic fibrosis) by introducing functional alleles into target cells using viral vectors. However, significant practical risks exist: viral vectors can trigger severe immune reactions, and off-target insertions can disrupt tumour suppressor genes, causing cancer. Ethical dilemmas include astronomical treatment costs creating unequal access, and moral controversies surrounding germline editing that permanently alters future generations.
discuss the potential importance for medicine of our increasing understanding of the human genome (to include: the ideas of predicting the likelihood of diseases occurring and their treatment by drugs which are targeted to genomes)
The sequencing of the human genome has transformed clinical medicine. Genomic understanding allows predicting an individual lifetime likelihood of developing non-communicable illnesses by screening for specific mutations, such as BRCA1 and BRCA2 alleles elevating breast and ovarian cancer risk, enabling proactive clinical screening or surgery. Furthermore, genomic insight underpins personalised medicine (pharmacogenomics), where drug selection and dosages are targeted to a patient specific genetic profile, optimising therapeutic efficacy while minimising adverse drug reactions. In oncology, tumour genome sequencing identifies driver mutations, allowing targeted biological therapies that selectively destroy cancer cells with minimal collateral damage.
Your focus
- Translate health data between graphical plots and numerical values.
- Calculate disease rates and percentages from epidemiological line and bar graphs.
- Interpret clinical risk indices such as body mass index and blood pressure categories.
Show all 87 objectives
- Construct and interpret frequency tables for medical and physiological datasets.
- Select and draw appropriate bar charts for discontinuous health categories with spaces between bars.
- Construct and interpret histograms for continuous biological variables such as age and blood pressure.
- Explain the principles of representative, unbiased sampling in clinical and medical trials.
- Describe how matching control and treatment cohorts controls for confounding variables.
- Evaluate how sample size impacts the detection of rare side effects and statistical validity of medical research.
- Identify positive, negative, or absent correlations from scatter diagrams of medical data.
- Draw accurate lines of best fit to summarize associations between paired variables.
- Distinguish between statistical correlation and biological causation using lifestyle disease examples.
- Calculate the radius from diameter measurements of bacterial colonies and inhibition zones.
- Apply the area formula πr² to calculate cross-sectional areas of clear agar zones.
- Compare the antimicrobial potency of different chemical treatments using calculated inhibition zone areas.
- Describe the comprehensive definition of health encompassing physical, mental, and social well-being.
- Define disease as an impairment of normal physiological functioning.
- Explain how physical and mental health interact dynamically in human populations.
- Describe the distinguishing features of communicable and non-communicable diseases.
- Identify biological pathogens responsible for transmitting communicable illnesses.
- Classify major human health conditions into communicable and non-communicable categories.
- Describe how immunodeficiency caused by HIV predisposes individuals to opportunistic infections such as tuberculosis.
- Explain how viral infection with HPV can initiate cellular changes resulting in cervical cancer.
- Describe broader interactions between infectious diseases, non-communicable illnesses, and mental health.
- Explain transmission mechanisms for viruses, bacteria, protists, and fungi in animal and plant populations.
- Describe how pathogen numbers and host immune defences determine the establishment of disease.
- Apply quantitative methods to estimate and model infected case numbers during disease outbreaks.
- Explain diagnostic methods for detecting pathogens including antigen test kits, DNA analysis, and visual symptom inspection.
- Describe preventative strategies to control disease spread in animal and human populations.
- Describe agricultural management practices used to prevent and reduce plant disease transmission.
- Describe representative human infections caused by viral, bacterial and fungal pathogens, including sexually transmitted HIV.
- Explain the progression from HIV infection to acquired immunodeficiency syndrome (AIDS).
- Describe specific plant diseases including tobacco mosaic virus, barley powdery mildew and crown gall disease.
- Describe how the waxy leaf cuticle provides a physical barrier against pathogen invasion.
- Explain the role of cellulose cell walls in preventing bacterial and fungal penetration into plant cells.
- Identify structural adaptations such as bark that protect plants from infectious disease.
- Describe the synthesis and function of antimicrobial chemical defences in plants.
- Identify natural antimicrobial substances produced by plants to defend against disease.
- Explain how chemical plant defences have provided the origin for modern medicinal drugs such as aspirin and digitalis.
- Describe field diagnostic procedures for identifying plant diseases using symptom observation, keys, and microscopy.
- Explain laboratory diagnostic methods based on monoclonal antibody antigen detection.
- Describe the use of DNA extraction and sequencing to identify plant pathogens definitively.
- Explain the structural adaptations of phagocytes and their role in engulfing and digesting pathogens.
- Describe the function of lymphocytes in producing specific antibodies and neutralising antitoxins.
- Explain how platelets initiate the blood clotting cascade to seal wounds and prevent pathogen entry.
- Describe the physical and chemical barrier functions of human skin.
- Explain how the respiratory tract uses mucus and ciliated epithelial cells to exclude airborne pathogens.
- Describe chemical defence mechanisms including stomach acid and lysozyme in tears.
- Explain how the immune system recognises pathogen antigens and produces specific complementary antibodies.
- Describe the cellular roles of lymphocytes and phagocytes in clearing systemic infections.
- Explain how the formation of immunological memory cells provides long-term immunity against reinfection.
- Describe the laboratory procedure for producing monoclonal antibodies using mice and myeloma cells.
- Explain the functional role of hybridoma cells in combining antibody synthesis with continuous cell division.
- Explain why monoclonal antibodies are identical and specific to a single antigenic epitope.
- Describe the mechanism of pregnancy testing strips using monoclonal antibodies to detect hCG hormone.
- Explain how monoclonal antibodies diagnose clinical conditions including prostate cancer via biomarker detection.
- Describe targeted cancer therapies delivering cytotoxic drugs specifically to malignant cells using monoclonal antibodies.
- Explain how vaccines stimulate active immunity and the generation of immunological memory.
- Distinguish between the targeted actions of antibiotics, antivirals, and topical antiseptics.
- Explain why antibiotics are ineffective against viral pathogens.
- Explain the necessity of aseptic techniques in preparing pure microbial cultures.
- Describe the sterilization of apparatus and media using autoclaving, alcohol disinfection, and Bunsen flaming.
- Explain procedural safeguards that prevent environmental contamination and inhibit growth of dangerous human pathogens.
- Describe preclinical laboratory testing using cells, tissues, and live animal models.
- Outline the phases of human clinical trials assessing drug safety, efficacy, and dosage.
- Explain the design and rationale of double-blind, placebo-controlled clinical trials in eliminating scientific bias.
- Recall that non-communicable diseases develop through the interaction of multiple genetic and lifestyle factors.
- Link specific risk factors to cardiovascular diseases, cancers, bronchitis and liver cirrhosis.
- Explain how poor nutrition and obesity increase the risk of type 2 diabetes through reduced cellular sensitivity to insulin.
- Evaluate lifestyle interventions in managing cardiovascular disease risk.
- Compare the therapeutic benefits and adverse side effects of pharmacological treatments such as statins.
- Evaluate surgical procedures including stents, bypass surgery and heart transplantation.
- Analyse how lifestyle choices including smoking, diet, and exercise affect non-communicable disease incidence at local community levels.
- Evaluate the national economic and healthcare impacts of obesity, diabetes, and cardiovascular diseases.
- Describe the global epidemiological shift from communicable to non-communicable diseases as nations industrialize.
- Describe the cellular origin of cancer through mutations leading to uncontrolled mitotic division and tumour formation.
- Contrast benign and malignant tumours in terms of tissue invasion and metastasis.
- Identify major environmental carcinogens and genetic risk factors that trigger oncogenic mutations.
- Discuss the therapeutic potential of embryonic and adult stem cells in treating human diseases and tissue injury.
- Explain clinical risks associated with stem cell therapies, including immune rejection and tumour formation.
- Evaluate ethical, moral, and social perspectives regarding the procurement and use of human embryonic stem cells.
- Explain the medical benefits of genetic engineering in synthesizing human therapeutic proteins such as insulin.
- Describe the principles, vectors, and practical hazards of somatic gene therapy in treating monogenic disorders.
- Evaluate the ethical, financial, and societal dilemmas associated with human genetic technologies.
- Discuss how human genome sequencing enables predictive screening for hereditary and complex diseases.
- Explain the principles of personalised medicine and pharmacogenomics in tailoring drug therapies to patient genomes.
- Evaluate the clinical benefits and ethical dilemmas associated with personal genomic testing.
Monitoring and maintaining health exam tips
Marking Points
- Extract numerical data from health and epidemiological graphs with correct units.
- Convert raw medical case numbers into standardized rates, such as cases per 100,000 people or percentages.
- Translate physiological measurements like blood pressure or body mass index into clinical risk categories.
- Construct and read frequency tables grouping clinical health data into appropriate class intervals.
- Draw bar charts with spaces between bars for discontinuous, categorical medical variables.
- Draw and interpret histograms with touching bars representing continuous physiological variables like age or blood pressure.
- Explain the necessity of representative, unbiased sampling in clinical trials and public health studies.
- Describe how matching patient cohorts for age, sex, and health status eliminates confounding variables.
- Explain why large sample sizes are required to identify rare adverse drug reactions and verify efficacy.
- Identify positive and negative correlations from scatter graphs plotting health risk variables.
- Draw an appropriate straight line of best fit through the scatter points, balancing points on either side.
- Explain that a correlation does not prove causation, which requires identifying a proven biological mechanism.
- Measure the diameter of the clear inhibition zone and divide by two to find the radius r.
- Apply the formula Area = πr² to calculate the cross-sectional area of clear agar or bacterial colonies.
- State the final calculated area with appropriate metric units (mm² or cm²) and significant figures.
- Conclude that larger inhibition zone areas demonstrate greater antimicrobial or antibiotic potency.
- Define health as a state of complete physical, mental, and social well-being, not just the absence of disease.
- Define disease as a disorder that impairs the normal physical or cellular functioning of an organism.
- Describe the relationship between health and disease as a dynamic balance influenced by biological and environmental factors.
- Describe communicable diseases as infectious diseases caused by pathogens that spread between individuals.
- Give examples of communicable diseases and their pathogens, such as influenza (virus) or cholera (bacterium).
- Describe non-communicable diseases as non-infectious conditions that cannot spread between people.
- Give examples of non-communicable diseases, such as coronary heart disease, stroke, or type 2 diabetes.
- Explain that HIV destroys white blood cells, weakening the immune system and increasing susceptibility to opportunistic infections like tuberculosis.
- Explain that persistent infection with Human Papillomavirus (HPV) triggers changes in cervical cells that lead to cervical cancer.
- State that physical illness can lower resistance to other infections or lead to mental health conditions like depression.
- Describe major transmission routes: airborne droplets, direct contact, contaminated food and water, vectors, and plant sap or splash.
- Explain how pathogen load influences the likelihood and severity of developing an infectious disease.
- Explain how epidemiologists track and estimate numbers of infected cases in populations using sampling and quantitative modelling.
- Explain diagnostic methods: visual identification of symptoms, detection of pathogen antigens using antibodies, and DNA testing.
- Describe prevention in humans and animals: hygiene, quarantine, barrier protection, vector control, and vaccination.
- Describe prevention in crops: removing and destroying infected plant tissue, crop rotation, and sterilising agricultural machinery.
- Describe one human infection for each pathogen type: viral measles (fever, red rash, airborne droplets), bacterial Salmonella (food poisoning with vomiting and diarrhoea) and fungal athlete's foot (itchy, peeling skin).
- Describe sexually transmitted infections in humans, including HIV as a retrovirus spread sexually or through blood, and distinguish HIV (the pathogen) from AIDS (the late-stage syndrome of immune deficiency).
- Explain how HIV leads to AIDS by destroying helper T cells, reducing immune function so opportunistic infections become life-threatening.
- Describe plant diseases: viral TMV causing mottled leaves, fungal Erysiphe graminis causing barley powdery mildew, and bacterial Agrobacterium tumefaciens causing crown gall tumours.
- Explain the TMV chain: mosaic discolouration means less chlorophyll, so less light absorbed, less photosynthesis, less glucose made and stunted growth.
- Describe the waxy leaf cuticle as a hydrophobic physical barrier preventing pathogen entry and water pooling on leaf surfaces.
- Describe the cellulose cell wall as a tough mechanical barrier surrounding plant cells that blocks pathogen penetration.
- Identify additional physical defences such as thick bark on stems that sloughs off to shed surface pathogens.
- Describe how plants produce antimicrobial chemicals to destroy or inhibit bacterial and fungal pathogens.
- Give examples of plant chemical defences, such as antibacterial allicin in garlic or tannins in witch hazel.
- Explain how plant defence compounds have been developed into human medicines, including aspirin from willow and digitalis from foxgloves.
- Describe field diagnosis methods: visual inspection of symptoms (spots, wilting, galls), identification keys, and field microscopy.
- Describe laboratory detection of pathogen antigens using monoclonal antibody testing kits.
- Describe laboratory detection of pathogen DNA using DNA extraction, PCR amplification, and sequencing.
- Explain why rapid laboratory identification is critical to preventing widespread agricultural epidemics.
- Explain how phagocytes are adapted: flexible cell membrane and lobed nucleus to squeeze through capillaries, engulfing pathogens and digesting them with lysosomal enzymes.
- Explain how lymphocytes are adapted: producing specific antibodies complementary to pathogen antigens and antitoxins to neutralise bacterial poisons.
- Explain how platelets are adapted: cell fragments that initiate blood clotting, forming insoluble fibrin meshes that trap blood cells to seal wounds against pathogens.
- Describe the skin as an unbroken physical barrier producing antimicrobial sebum to prevent pathogen penetration.
- Describe respiratory defences: goblet cells producing mucus to trap pathogens and cilia sweeping mucus up to the throat to be swallowed.
- Describe chemical defences: stomach hydrochloric acid destroying ingested pathogens, and tear lysozyme breaking down bacterial cell walls.
- Explain that antigens are unique molecular surface markers on pathogens recognised as non-self by lymphocytes.
- Describe how lymphocytes produce specific antibodies complementary to antigens, causing agglutination and tagging pathogens for phagocytosis.
- Explain that memory cells persist after infection, producing a faster and greater antibody response upon secondary exposure (immunity).
- Describe injecting a mouse with a specific antigen to stimulate B lymphocytes to produce complementary antibodies.
- Describe extracting spleen lymphocytes and fusing them with tumour (myeloma) cells to create hybridoma cells.
- Explain that hybridoma cells can divide indefinitely while producing specific identical antibodies.
- Describe cloning the hybridoma cell and harvesting large quantities of identical monoclonal antibodies.
- Describe how pregnancy tests use monoclonal antibodies bound to coloured dye to detect the hormone hCG in urine.
- Describe diagnostic disease detection, such as using monoclonal antibodies to detect prostate-specific antigen (PSA) for prostate cancer.
- Describe targeted cancer therapy: monoclonal antibodies bound to radioactive substances or cytotoxic drugs binding specifically to tumour antigens to destroy cancer cells without damaging healthy body cells.
- Explain that vaccines introduce dead, attenuated, or fragment pathogens to stimulate lymphocyte antibody production and memory cell formation without causing disease.
- Explain that antibiotics specifically kill bacteria or inhibit their growth (such as disrupting cell wall synthesis), but cannot treat viral infections.
- Describe antivirals as drugs that inhibit viral replication inside host cells, and antiseptics as chemical agents applied externally to skin to kill microbes.
- Explain that autoclaving sterilises glassware and nutrient agar growth media at high temperature and pressure (121 °C).
- Describe flaming wire inoculating loops in a roaring blue Bunsen flame to sterilise them by incinerating contaminating microorganisms.
- Explain that working near a lit Bunsen burner creates upward convection currents that prevent airborne microbes from falling into media.
- Describe securing the Petri dish lid with tape without sealing completely to allow aerobic conditions, incubating inverted at maximum 25 °C in schools.
- Describe preclinical testing in laboratories using cultured human cells, tissues, and live animals to evaluate toxicity, efficacy, and dosage.
- Describe clinical trials Phase 1 on healthy human volunteers at very low doses to test safety and side effects.
- Describe clinical trials Phase 2 and 3 on patients suffering from the target disease to test efficacy, determine optimum dosage, and monitor rare side effects.
- Explain double-blind placebo-controlled trials, where neither patients nor doctors know who receives the real drug, eliminating bias.
- Recall that non-communicable diseases result from interactions between genetic, lifestyle and environmental factors, not a single cause.
- Link specific risk factors to cardiovascular disease (saturated fat in the diet, hypertension, smoking, lack of exercise) and to bronchitis (tobacco smoke, particulates).
- Link excessive alcohol consumption and hepatitis infections to liver cirrhosis, and poor nutrition with obesity to an increased risk of type 2 diabetes.
- Explain that risk factors increase the probability of developing a disease without guaranteeing that it will occur.
- Distinguish type 1 diabetes (autoimmune destruction of insulin-producing pancreatic cells) from type 2 diabetes (reduced cellular sensitivity to insulin, linked to obesity).
- Many cancers involve interacting genetic and environmental risk factors: tobacco smoke contains carcinogens that can damage DNA, while inherited variants can affect susceptibility. Exposure increases risk without making cancer inevitable.
- Evaluate lifestyle modifications: non-invasive and effective at lowering blood pressure, but depend on patient adherence, cannot unblock established plaques and exercise carries some injury risk.
- Evaluate medical treatments such as statins and antihypertensives: they lower blood cholesterol and reduce clot risk, but require lifelong daily use and may cause side effects such as muscle aches or liver dysfunction.
- Evaluate surgical interventions such as stents, bypass grafts and heart transplants: they can restore blood flow quickly, but carry operative risks of infection and thrombosis, and transplants risk rejection requiring lifelong immunosuppressants.
- For each treatment category, give at least one clear advantage and one clear disadvantage, and compare categories rather than describing them in isolation.
- Analyse local health patterns: socioeconomic deprivation correlates with higher smoking, poorer nutrition, and elevated cardiovascular disease mortality.
- Analyse national impacts: high prevalence of obesity and type 2 diabetes linked to sedentary lifestyles and high-calorie diets, placing immense financial strain on healthcare services.
- Analyse global transitions: industrialisation and adoption of Western diets and tobacco increase global non-communicable disease burdens over communicable illnesses.
- Describe cancer as resulting from mutations in cells that cause uncontrolled growth and mitotic division, forming a tumour.
- Describe benign tumours: abnormal cell masses contained within a membrane that do not invade surrounding tissues or spread.
- Describe malignant tumours: cancerous cells that invade surrounding tissues, break off, and travel via blood or lymph to form secondary tumours (metastases).
- Identify carcinogens, such as UV radiation, ionising radiation, and chemicals in tobacco smoke, as agents causing cancer mutations.
- Describe potential medical benefits: embryonic stem cells can differentiate into any cell type, replacing damaged tissues to treat paralysis, diabetes, or blindness.
- Explain clinical risks: transplanted donor stem cells can be rejected by the recipient immune system, requiring immunosuppressive drugs.
- Explain additional hazards: rapidly dividing stem cells can mutate and form tumours, or transmit viral infections from donor cultures.
- Discuss ethical objections regarding the destruction of human embryos in stem cell research.
- Explain medical benefits: producing pure human therapeutic proteins (like insulin) in bacteria, and gene therapy replacing faulty alleles in monogenic disorders.
- Describe practical risks: viral vectors triggering immune responses or causing off-target mutations that disrupt tumour suppressor genes, causing cancer.
- Discuss ethical and practical dilemmas: high treatment costs leading to social inequality, and moral controversies surrounding germline genetic modification.
- Discuss predicting disease risk: genetic screening identifies inherited mutations (such as BRCA genes for cancer), enabling preventative lifestyle changes or surgery.
- Discuss personalised medicine (pharmacogenomics): designing and prescribing drugs tailored to an individual specific genetic makeup to maximize efficacy and minimize side effects.
- Discuss targeted oncology: sequencing tumour genomes to select targeted biological therapies that specifically attack cancer mutations.
- Identify ethical and social concerns: genetic discrimination by insurers or employers, and psychological anxiety caused by predicting incurable conditions.
Examiner Tips
- 💡Check axis labels for multipliers such as in thousands or rate per 100,000 before recording numerical answers.
- 💡Show full working when calculating disease incidence rates or converting raw counts into percentages.
- 💡Remember: discrete categories like pathogen type need separate bars with gaps; continuous measurements like mass or age touch.
- 💡Ensure frequency scales start at zero unless a clear break in the axis is explicitly indicated.
- 💡State that large sample sizes reduce the effect of individual anomalies and allow rare side effects to be discovered.
- 💡Always mention matching control groups for age, sex, and lifestyle to ensure a fair comparison.
- 💡State clearly: correlation does not mean causation. Proving causation requires identifying a biological mechanism, such as tar containing carcinogens that mutate DNA.
- 💡When identifying correlations on a scatter graph, state whether it is positive, negative, or shows no correlation.
- 💡Always divide the measured diameter by 2 first to get the radius before squaring.
- 💡Use the π button on your calculator or 3.142 as specified in the exam paper, and quote your answer with units of mm².
- 💡Memorise the WHO definition: complete physical, mental, and social well-being.
- 💡Be prepared to explain how poor physical health can lead to mental health disorders such as depression.
- 💡Always state whether a disease is caused by a pathogen when defining communicable diseases.
- 💡Link non-communicable diseases explicitly to lifestyle risk factors, genetics, and environment.
- 💡Use precise phrasing: HIV weakens the immune system so pathogens like tuberculosis cannot be fought off.
- 💡Mention the HPV vaccine as a preventative measure against cervical cancer.
- 💡Always state the specific transmission route for each pathogen rather than writing 'caught from someone'.
- 💡Distinguish clearly between the vector carrying a disease and the microscopic pathogen causing it.
- 💡Link diagnostic techniques (antigen detection or DNA testing) directly to their purpose: early identification to isolate infected individuals.
- 💡For plant disease control, state that infected plants must be burned or destroyed, never placed in compost where spores survive.
- 💡For TMV, always give the full chain: mosaic pattern, less chlorophyll, less light absorbed, less photosynthesis, less glucose, stunted growth.
- 💡When describing Agrobacterium tumefaciens, state that it transfers bacterial plasmid DNA into plant cells, producing crown gall tumours.
- 💡Specify the biochemical components: waxy cuticle is made of waterproof lipids; cell wall is made of cellulose fibres.
- 💡Explain that the cuticle repels water, which stops fungal spores from germinating because spores require moisture to grow.
- 💡Learn the standard drug examples: aspirin comes from willow bark; digitalis comes from foxgloves.
- 💡State that antimicrobial chemicals either kill microorganisms directly or inhibit their growth and reproduction.
- 💡Structure your answer into two distinct locations: IN THE FIELD (observation of symptoms, keys, light microscopy) versus IN THE LAB (monoclonal antibodies for antigens, DNA analysis/PCR).
- 💡Mention that laboratory testing is necessary when visual symptoms are non-specific or ambiguous.
- 💡Clearly distinguish between the two types of white blood cells: phagocytes engulf and digest; lymphocytes produce specific antibodies and antitoxins.
- 💡For platelets, emphasize that clotting creates a physical barrier (scab) that seals wounds to prevent pathogen entry.
- 💡Organise answers by body system: skin (physical barrier and sebum), respiratory system (mucus and cilia), stomach (hydrochloric acid), eyes (lysozyme in tears).
- 💡State clearly that hydrochloric acid in the stomach has a low pH that denatures pathogen enzymes.
- 💡Contrast primary and secondary immune responses: primary is slow and produces low antibody titres; secondary is rapid, producing higher antibody levels that destroy pathogens before symptoms appear.
- 💡Always state that antibodies have a complementary shape that binds specifically to the pathogen antigen.
- 💡Memorise the fusion equation: mouse B lymphocyte + myeloma tumour cell = hybridoma cell.
- 💡State clearly why myeloma cells are used: they divide rapidly and indefinitely in culture.
- 💡For cancer treatment, emphasize the advantage: targeted delivery means healthy cells are unharmed, causing fewer side effects than conventional chemotherapy.
- 💡In pregnancy tests, identify the target antigen explicitly as the hormone hCG found in urine.
- 💡State clearly: antibiotics kill bacteria only; they do not kill viruses because viruses live inside host cells and lack bacterial cell walls.
- 💡Explain herd immunity as vaccinating a large proportion of a population so that pathogens cannot spread, protecting vulnerable unvaccinated individuals.
- 💡Explain that incubating plates inverted (upside down) prevents condensation droplets from dripping onto the agar surface and ruining colonies.
- 💡Always state that school cultures must be incubated at 25 °C or below to prevent the growth of human pathogens that thrive at 37 °C body temperature.
- 💡Clearly distinguish between toxicity (is it harmful?), efficacy (does it work?), and dosage (how much is needed?).
- 💡Explain that double-blind trials eliminate psychological bias from patients (placebo effect) and subjective bias from doctors analysing results.
- 💡State clearly that lifestyle risk factors increase the probability of developing a non-communicable disease, rather than guaranteeing it.
- 💡When discussing type 2 diabetes, link high-sugar diet and obesity to body cells responding less well to insulin, and avoid claiming a single deterministic cause.
- 💡Structure evaluation answers into three categories: lifestyle (diet, exercise, smoking), medical (statins, antihypertensives) and surgical (stents, bypass, transplants).
- 💡For each category, state at least one advantage and one disadvantage, then compare categories to reach a supported judgement.
- 💡Make sure your response explicitly addresses all three spatial scales: local (community inequalities), national (healthcare costs like NHS), and global (developing country transitions).
- 💡Reference specific lifestyle factors: smoking, alcohol consumption, high-fat diet, and physical inactivity.
- 💡Clearly distinguish benign from malignant: benign tumours remain localized within a membrane; malignant tumours invade tissues and spread via blood to form secondary tumours.
- 💡Always state that cancer involves uncontrolled cell division by MITOSIS.
- 💡Balance your response with both medical benefits (tissue replacement) and clinical risks (rejection, tumour development, viral infection).
- 💡When discussing ethics, mention that some people believe a human embryo has the moral status of a human life from fertilisation.
- 💡Use insulin production in GM bacteria as a clear example of successful medical gene technology.
- 💡Clearly contrast somatic cell gene therapy (affects patient only) with germline gene editing (inherited by future generations, raising major ethical concerns).
- 💡Use the terms personalised medicine and targeted drugs when answering questions on the future of genomics in healthcare.
- 💡Cite BRCA gene screening as a real-world example of predicting disease likelihood and guiding preventative clinical care.
Common Mistakes
- Misreading axes when values are plotted per 100,000 population, treating them as simple raw headcounts.
- Failing to calculate percentage changes between baseline and elevated disease risk levels.
- Drawing touching bars for categorical data like blood groups, incorrectly treating it as continuous data.
- Leaving irregular gaps between bars on a bar chart or failing to label class widths on a histogram.
- Assuming a small clinical trial with ten volunteers provides sufficient evidence to license a new drug.
- Overlooking confounding variables like diet, smoking, or age when selecting participant sample groups.
- Assuming that a strong correlation automatically proves one factor directly causes the other.
- Forcing the line of best fit on a scatter plot through the origin when the data trend does not intercept zero.
- Squaring the diameter directly in the formula rather than first halving it to find the radius.
- Writing incorrect units such as mm rather than mm² for cross-sectional area.
- Defining health simply as not being sick, omitting mental and social components of well-being.
- Assuming diseases only affect physical organs, ignoring the profound impact on mental health.
- Thinking non-communicable diseases can be transmitted through close contact or shared utensils.
- Confusing genetic disorders with communicable diseases, not understanding that inherited alleles are not pathogens.
- Stating that HIV causes tuberculosis directly, rather than explaining that HIV damages the immune system so TB bacteria can cause disease.
- Believing HPV is a bacterial infection rather than a sexually transmitted virus.
- Confusing the pathogen (such as Plasmodium) with the vector (such as the female Anopheles mosquito).
- Assuming all bacteria and viruses transmit in the same manner, overlooking specific transmission vectors.
- Prescribing antibiotics for viral or fungal infections, where they are completely ineffective.
- Assuming visual identification is always sufficient, overlooking asymptomatic carriers and the need for molecular antigen or DNA tests.
- Writing 'athlete foot' instead of the correct term athlete's foot.
- Treating HIV and AIDS as identical: HIV is the virus; AIDS is the late-stage syndrome of immune deficiency that may develop after HIV infection.
- Stopping at 'TMV makes leaves mottled' without linking this to reduced chlorophyll, reduced light absorption, reduced photosynthesis and stunted growth.
- Calling the waxy cuticle a cell wall, failing to distinguish the acellular waxy layer from the cellular cellulose wall.
- Believing the plant cell wall is completely impenetrable, forgetting that fungal pathogens can secrete enzymes like cellulase.
- Thinking plants have antibodies like animals, rather than non-specific antimicrobial chemicals.
- Confusing physical defences (spines, cuticle) with chemical responses (antimicrobial substances, poisons).
- Assuming visual field inspection is completely reliable, overlooking that different pathogens can cause identical wilting or yellowing symptoms.
- Confusing antigen testing (detecting unique pathogen surface proteins) with DNA testing (detecting pathogen genetic sequences).
- Stating that white blood cells eat pathogens rather than engulfing and digesting them by phagocytosis.
- Confusing antibodies (proteins produced by lymphocytes) with antigens (molecules on pathogen surfaces) or antibiotics (medicines).
- Claiming stomach acid breaks down food only, ignoring its vital antimicrobial role in killing ingested pathogens.
- Describing non-specific defences as producing antibodies, failing to realise they act universally without antigen specificity.
- Confusing antigens (pathogen markers) with antibodies (proteins secreted by white blood cells).
- Stating that memory cells remember how to fight rather than explaining they divide rapidly into antibody-producing plasma cells.
- Thinking lymphocytes divide continuously on their own without needing fusion with myeloma tumour cells.
- Believing the mouse produces monoclonal antibodies directly in its bloodstream rather than harvesting hybridomas in culture.
- Claiming monoclonal antibodies cure all cancers directly without needing attached cytotoxic drugs or radioactive tags.
- Confusing the mobile antibodies and immobilised antibodies in pregnancy test strip mechanisms.
- Demanding antibiotics for viral infections like colds or influenza, failing to recognize that viruses reproduce inside host cells and lack bacterial structures like peptidoglycan walls.
- Thinking vaccines contain antibodies rather than antigens that stimulate the recipient immune system to produce its own antibodies.
- Sealing Petri dishes completely with tape, which creates anaerobic conditions that encourage the growth of dangerous pathogenic bacteria.
- Using an inoculating loop immediately after flaming, which kills the bacteria being sampled due to extreme heat.
- Thinking Phase 1 clinical trials test whether the drug cures the illness, rather than checking safety on healthy volunteers.
- Believing a placebo is a poison, rather than an inert substance (such as a sugar pill) containing no active medicine.
- Believing non-communicable diseases have a single cause rather than multiple interacting risk factors.
- Confusing type 1 diabetes (autoimmune destruction of insulin-producing pancreatic cells) with type 2 diabetes (reduced cellular response to insulin, linked to obesity).
- Writing that poor nutrition and obesity 'directly cause' type 2 diabetes; they increase the risk, and other factors such as genetics also contribute.
- Assuming statins dissolve existing coronary plaques instantly; they reduce liver cholesterol synthesis to slow further plaque growth.
- Stating that heart bypass surgery cures cardiovascular disease permanently without the need for ongoing healthy lifestyle maintenance.
- Claiming lifestyle changes have no risks at all; exercise can cause injury and dietary change can have other effects.
- Writing about disease at an individual level only, ignoring the requirement to analyse local, national, and global public health trends.
- Assuming infectious diseases remain the primary cause of mortality in all countries globally.
- Calling all tumours cancerous, failing to recognize that benign tumours are non-cancerous and do not metastasize.
- Claiming cancer cells spread by walking or floating through the body, rather than travelling through blood vessels or lymph vessels.
- Claiming adult bone marrow stem cells can differentiate into any cell type, confusing them with pluripotent embryonic stem cells.
- Ignoring the risk of tumour formation when discussing the safety of stem cell therapy.
- Thinking somatic gene therapy alters the DNA of the patient offspring, failing to distinguish somatic cells from germline sperm and egg cells.
- Assuming gene therapy is 100% effective today, overlooking technical challenges in delivering genes into enough target cells.
- Assuming carrying a faulty allele like BRCA guarantees developing cancer, rather than indicating an elevated statistical risk.
- Ignoring ethical concerns like genetic privacy and the psychological distress of knowing one has high risk for an incurable disease.